236 related articles for article (PubMed ID: 16305725)
1. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
[TBL] [Abstract][Full Text] [Related]
2. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
3. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
[TBL] [Abstract][Full Text] [Related]
4. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
5. Budesonide for the treatment of collagenous colitis: first results of a pilot trial.
Tromm A; Griga T; Möllmann HW; May B; Müller KM; Fisseler-Eckhoff A
Am J Gastroenterol; 1999 Jul; 94(7):1871-5. PubMed ID: 10406251
[TBL] [Abstract][Full Text] [Related]
6. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
[TBL] [Abstract][Full Text] [Related]
7. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: budesonide treatment for collagenous colitis.
Feyen B; Wall GC; Finnerty EP; DeWitt JE; Reyes RS
Aliment Pharmacol Ther; 2004 Oct; 20(7):745-9. PubMed ID: 15379834
[TBL] [Abstract][Full Text] [Related]
9. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
Münch A; Söderholm JD; Ost A; Ström M
Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
[TBL] [Abstract][Full Text] [Related]
10. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
Münch A; Bohr J; Miehlke S; Benoni C; Olesen M; Öst Å; Strandberg L; Hellström PM; Hertervig E; Armerding P; Stehlik J; Lindberg G; Björk J; Lapidus A; Löfberg R; Bonderup O; Avnström S; Rössle M; Dilger K; Mueller R; Greinwald R; Tysk C; Ström M;
Gut; 2016 Jan; 65(1):47-56. PubMed ID: 25425655
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of collagenous colitis over a period of 10 years.
Madisch A; Miehlke S; Lindner M; Bethke B; Stolte M
Z Gastroenterol; 2006 Sep; 44(9):971-4. PubMed ID: 16981069
[TBL] [Abstract][Full Text] [Related]
12. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
13. Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Hanauer S; Sandborn WJ; Persson A; Persson T
Aliment Pharmacol Ther; 2005 Feb; 21(4):363-71. PubMed ID: 15709986
[TBL] [Abstract][Full Text] [Related]
14. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
Sandborn WJ; Löfberg R; Feagan BG; Hanauer SB; Campieri M; Greenberg GR
Am J Gastroenterol; 2005 Aug; 100(8):1780-7. PubMed ID: 16086715
[TBL] [Abstract][Full Text] [Related]
15. Collagenous colitis: description of a single centre series of 83 patients.
Jobse P; Flens MJ; Loffeld RJ
Eur J Intern Med; 2009 Sep; 20(5):499-502. PubMed ID: 19712853
[TBL] [Abstract][Full Text] [Related]
16. Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.
Fernández-Bañares F; Salas A; Esteve M; Espinós J; Forné M; Viver JM
Am J Gastroenterol; 2003 Feb; 98(2):340-7. PubMed ID: 12591052
[TBL] [Abstract][Full Text] [Related]
17. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
18. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
Gross V
Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
[TBL] [Abstract][Full Text] [Related]
19. Interventions for treating collagenous colitis.
Chande N; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2006 Oct; (4):CD003575. PubMed ID: 17054177
[TBL] [Abstract][Full Text] [Related]
20. Oral budesonide therapy improves quality of life in patients with collagenous colitis.
Madisch A; Heymer P; Voss C; Wigginghaus B; Bästlein E; Bayerdörffer E; Meier E; Schimming W; Bethke B; Stolte M; Miehlke S
Int J Colorectal Dis; 2005 Jul; 20(4):312-6. PubMed ID: 15549326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
